Evidence map›Paper›PMID 20194719›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Effects of MHC class I alleles on licensing of Ly49A+ NK cells.

A Helena Jonsson, Liping Yang, Sungjin Kim, Samantha M Taffner, Wayne M Yokoyama

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. H2-K1 protects murineHaematologica · 2025
    Article
  3. Review
  4. Inhibitory KIR2DL2 Gene: Risk for Deep Endometriosis in Euro-descendants.Reproductive sciences (Thousand Oaks, Calif.) · 2021
    Article
  5. Article
  6. Article
  7. Chronic Ly49H Receptor EngagementFrontiers in immunology · 2019
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

A Helena JonssonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Liping Yang
Sungjin Kim
Samantha M Taffner
Wayne M Yokoyama
Center for Rheumatology · USHoward Hughes Medical Institute · USNational Student Clearinghouse Research Center · US

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI WEIHL, CONRAD C · 2001 to 2015
$8.9M
INVIVO DEVELOPMENT OF NATURAL KILLER CELLSR01AI033903 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1992 to 2015
$4.0M
Activation Receptors on NK CellsR37AI034385 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2002 to 2011
$2.6M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI033903NIAID NIH HHS R37 AI034385NIAMS NIH HHS P30 AR048335
6 · The paper itself

Abstract

NK cells are innate immune lymphocytes that can react to cells lacking self-MHC class I. However, NK cells that cannot engage self-MHC through an inhibitory receptor are resistant to stimulation through their activation receptors. To become licensed (i.e., functionally competent to be triggered through its activation receptors), an NK cell must engage host MHC class I via a MHC class I-specific inhibitory receptor, such as a member of the murine Ly49 family. To explore potential determinants of NK cell licensing on a single Ly49 receptor, we have investigated the relative licensing impacts of the b, d, k, q, r, and s H2 haplotypes on Ly49A(+) NK cells. The results indicate that licensing is essentially analog but is saturated by moderate-binding MHC class I ligands. Interestingly, licensing exhibited a strong inverse correlation with a measure of cis engagement of Ly49A. Finally, licensing of Ly49A(+) NK cells was found to be less sensitive to MHC class I engagement than Ly49A-mediated effector inhibition, suggesting that licensing establishes a margin of safety against NK cell autoreactivity.

Indexed as

AllelesAnimalsCell SeparationCytotoxicity, ImmunologicFlow CytometryHaplotypesHistocompatibility Antigens Class IKiller Cells, NaturalLymphocyte ActivationMiceMice, TransgenicNK Cell Lectin-Like Receptor Subfamily AHistocompatibility Antigens Class IKlra1 protein, mouseNK Cell Lectin-Like Receptor Subfamily A

Identifiers

PMID20194719
PMCPMC2862662
OpenAlexW2160174030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.